Yang Peiying, Sun Yun, Wang Xin, Ma Dingyuan, Wang Yanyun, Zhang Zhilei, Jiang Tao
Genetic Medicine Center, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University (Nanjing Maternal and Child Health Care Hospital), Nanjing, Jiangsu 210004, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024 Mar 10;41(3):278-283. doi: 10.3760/cma.j.cn511374-20210623-00532.
To explore the pathogenicity and genotype-phenotype correlation of the c.158G>A variant of phenylalanine hydroxylase (PAH) gene among patients with PAH deficiency.
Thirty seven children diagnosed with PAH deficiency at the Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University between July 2016 and June 2021 were selected as the study subjects. Clinical data and results of genetic testing were retrospectively analyzed.
Among the 37 patients, mild hyperphenylalaninemia (HPA) was observed in 34 cases, two PAH variants (including c.158G>A), which formed a compound heterozygous mutation genotype, were detected in 33 patients, and the remainder one was found to harbor three PAH variants, including homozygous c.158G>A variants and a heterozygous c.842+2T>A variant. Classical phenylketonuria (PKU) was observed in 3 patients, and three PAH variants were detected in each of them, including two with c.[158G>A,842+2T>A]/c.728G>A and c.[158G>A,842+2T>A]/c.611A>G, respectively, and one with c.[158G>A, c.722G>A]/c.728G>A. The c.158G>A variant has a minimal influence on the PAH activity and is associated with a mild HPA phenotype. The variant should thereby be classified as likely benign.
When the c.158G>A variant and other pathogenic variants are arranged in cis position, the ultimate phenotype will be determined by the pathogenicity of other variants.
探讨苯丙氨酸羟化酶(PAH)基因c.158G>A变异在PAH缺乏症患者中的致病性及基因型-表型相关性。
选取2016年7月至2021年6月在南京医科大学附属妇产医院确诊为PAH缺乏症的37例患儿作为研究对象。对临床资料及基因检测结果进行回顾性分析。
37例患者中,34例表现为轻度高苯丙氨酸血症(HPA);33例检测到两个PAH变异(包括c.158G>A),形成复合杂合突变基因型;其余1例检测到三个PAH变异,包括纯合的c.158G>A变异和杂合的c.842+2T>A变异。3例患者表现为经典型苯丙酮尿症(PKU),均检测到三个PAH变异,其中两例分别为c.[158G>A,842+2T>A]/c.728G>A和c.[158G>A,842+2T>A]/c.611A>G,另一例为c.[158G>A, c.722G>A]/c.728G>A。c.158G>A变异对PAH活性影响极小,与轻度HPA表型相关,该变异应分类为可能良性。
当c.158G>A变异与其他致病变异呈顺式排列时,最终表型将由其他变异的致病性决定。